Free for Members - 2020 PharmSci 360 Content On Demand
AAPS members will have exclusive access to the 2020 conference content including the Prologues, Symposiums, Keynotes, and Partner Presentations. This content will be available for one year and does not include the Plenary Sessions and Rapid Fires.
Log-in and view the content.
Not a member? Join now!
Partner Presentations
Accurate Nitrosamines Evaluation in ARB and Ranitidine-Based Drugs Topic
Presented by Agilent Technologies
Addressing Challenges in Oral Solid Dosage Form Development & Manufacturing Pt. 1
Presented by BASF Corporation
Addressing Challenges in Oral Solid Dosage Form Development & Manufacturing Pt. 2
Presented by BASF Corporation
Addressing Technical Challenges in Development Drug Products: a CDMO Perspective
Presented by Thermo Fisher Scientific
Comprehensive GC-MS and LC-MS Solutions to Meet the Needs for Confident and Compliant Analysis of Nitrosamine Impurities
Presented by Thermo Fisher Scientific
COVID-19 Trials: Strategies to Ensure Success
Presented by PPD Laboratories
Data-Driven Strategies to Accelerate Your Molecule’s Development Path
Presented by Catalent, Inc.
Developing Modified Release Versions of Immediate Release Solid Dosage Forms
Presented by Recro
Efficient Methods for Analysis of Monoclonal Antibody Critical Quality Attributes
Presented by Agilent Technologies
Emerging Therapeutic Modalities: Challenges and Considerations in Developing Successful Programs
Presented by WuXi AppTec
Extrusion Technologies for Pharmaceutical Dosage Forms
Presented by Foster Delivery Science, Inc.
Facilitating Process Economy in GMP Applications with the Octet Platform
Presented by ForteBio, A Sartorius Brand
Gentle Drying for Thermosensitive Active: Electrostatic Spray Dryer
Presented by Fluid Air Inc.
Lipid-based Excipients for Skin Permeation by In Vitro Permeation Studies
Presented by BASF
Method Development Strategies for Protein Characterization by Intact/Subunit HPLC
Presented by Phenomenex
Miniaturized Separations and Increased Sensitivity with Micro/Nano Scale HPLC
Presented by Phenomenex
MRM Based Peptide Quantification Using a Novel Triple Quadrupole Instrument
Presented by SCIEX
Overcoming Drug Interference and Shrinking Sample Volumes in ADA Immunoassays
Presented by Gyros Protein Technologies
Patient-Centric Dosage Forms: Strategies for Compliance in Special Populations
Presented by Adare Pharma Solutions
Patient-Focused Drug Design: A Structured Approach to Dose Form Design
Presented by Catalent, Inc.
Protecting APIs with Solid Form Patents- Drug Development and/or Repositioning
Presented by Barash Law, LLC
Recent Developments in LC-MS-based Bioanalysis of Biopharmaceutical Drugs
Presented by PRA Health Sciences
Redefining Early-Stage Physicochemical Measurement
Presented by Solubility Company
Reducing Uncertainty using a Multidetector Approach in Extractables and Leachables
Presented by Agilent Technologies
Small Batch Continuous Production at a 9 Sigma Level
Presented by Syntegon
The Absorption Driven Drug Formulation Concept
Presented by Pion Inc.
U/HPLC Reversed-Phase Method Development: Selecting a Reproducible Starting Point
Presented by Phenomenex
Utilizing Octet Platform for Characterizing Critical Reagents in Support of Drug Development for Contemporary Biotherapeutics
Presented by B2S Life Sciences
Free for Members - 2020 PharmSci 360 Poster Collection
AAPS members will have exclusive access to the 2020 conference posters for one year. Visit .
Log-in and view the posters.
Not a member? Join now!
Software Labs
Fast and Easy CFR 21 Part 11 Compliance for Microscopes
Presented by Quartz Imaging Corporation
Software Solutions for Successful Pharmaceutical LC-MS and GC-MS Impurity Analysis, Characterization - and Quality Control
Presented by Thermo Fisher Scientific
Tech Challenge
Discover Raw Material ID through Opaque Containers
Presented by Agilent Technologies
PART 4: COVID-19 – Immunogenicity in the Time of COVID
January 20-21, 2021 | Virtual event
AAPS has added two more dates and four more sessions to this event! Join us January 20-21, for a continuation of COVID-19: Current Pharmaceutical Developments for Cures and Prevention.
The workshop continues to be free to members of AAPS. Join or renew now to participate in the upcoming sessions, or to access recordings from the workshop. Membership begins at $175 per year. Purchases for nonmembers begin at $395 per session.
January 20, 2021
Session 1: Overview of the Immune Response to SARS-CoV-2, Hyperinflammation and Cytokines
January 21, 2021
Session 2: Immunogenicity Considerations for Therapeutic Proteins in COVID Patients
View the agenda and register now!